-
Thoracic Surgery Clinics Nov 2023Lung cancer screening has been shown to reduce lung cancer mortality and is recommended for individuals meeting age and smoking history criteria. Despite the expansion... (Review)
Review
Lung cancer screening has been shown to reduce lung cancer mortality and is recommended for individuals meeting age and smoking history criteria. Despite the expansion of lung cancer screening guidelines in 2021, racial/ethnic and sex disparities persist. High-risk racial minorities and women are more likely to be diagnosed with lung cancer at younger ages and have lower smoking histories when compared with White and male counterparts, resulting in higher rates of ineligibility for screening. Risk prediction models, biomarkers, and deep learning may help refine the selection of individuals who would benefit from screening.
Topics: Humans; Male; Female; Lung Neoplasms; Smoking; Early Detection of Cancer; Lung; Mass Screening
PubMed: 37806735
DOI: 10.1016/j.thorsurg.2023.04.002 -
Thoracic Surgery Clinics Nov 2023Lung cancer is the leading cause of cancer-related mortality in Japan and worldwide. Early detection of lung cancer is an important strategy for decreasing mortality.... (Review)
Review
Lung cancer is the leading cause of cancer-related mortality in Japan and worldwide. Early detection of lung cancer is an important strategy for decreasing mortality. Advances in diagnostic imaging have made it possible to detect lung cancer at an early stage in medical practice. Conversely, screening of asymptomatic healthy populations is recommended only when the evidence shows the benefits of regular intervention. Due to a variety of evidence and racial differences, screening methods vary from country to country. This article focused on the perspective of lung cancer screening in Japan.
Topics: Humans; Lung Neoplasms; Early Detection of Cancer; Tomography, X-Ray Computed; Radiography, Thoracic; Sputum; Mass Screening
PubMed: 37806741
DOI: 10.1016/j.thorsurg.2023.03.004 -
Radiologic Clinics of North America Jul 2024The goal of screening is to detect breast cancers when still curable to decrease breast cancer-specific mortality. Breast cancer screening in the United States is... (Review)
Review
The goal of screening is to detect breast cancers when still curable to decrease breast cancer-specific mortality. Breast cancer screening in the United States is routinely performed with digital mammography and digital breast tomosynthesis. This article reviews breast cancer doubling time by tumor subtype and examines the impact of doubling time on breast cancer screening intervals. By the article's end, the reader will be better equipped to have informed discussions with patients and medical professionals regarding the benefits and disadvantages of the currently recommended screening mammography intervals.
Topics: Humans; Breast Neoplasms; Mammography; Female; Early Detection of Cancer; Time Factors; Mass Screening; Breast
PubMed: 38777534
DOI: 10.1016/j.rcl.2023.12.011 -
Radiologic Clinics of North America Jul 2024Interval breast cancers are not detected at routine screening and are diagnosed in the interval between screening examinations. A variety of factors contribute to... (Review)
Review
Interval breast cancers are not detected at routine screening and are diagnosed in the interval between screening examinations. A variety of factors contribute to interval cancers, including patient and tumor characteristics as well as the screening technique and frequency. The interval cancer rate is an important metric by which the effectiveness of screening may be assessed and may serve as a surrogate for mortality benefit.
Topics: Humans; Breast Neoplasms; Early Detection of Cancer; Female; Mammography; Mass Screening; Time Factors
PubMed: 38777533
DOI: 10.1016/j.rcl.2023.12.012 -
Journal of Magnetic Resonance Imaging :... Oct 2023Population-based breast cancer screening using mammography as the gold standard imaging modality has been in clinical practice for over 40 years. However, the... (Review)
Review
Population-based breast cancer screening using mammography as the gold standard imaging modality has been in clinical practice for over 40 years. However, the limitations of mammography in terms of sensitivity and high false-positive rates, particularly in high-risk women, challenge the indiscriminate nature of population-based screening. Additionally, in light of expanding research on new breast cancer risk factors, there is a growing consensus that breast cancer screening should move toward a risk-adapted approach. Recent advancements in breast imaging technology, including contrast material-enhanced mammography (CEM), ultrasound (US) (automated-breast US, Doppler, elastography US), and especially magnetic resonance imaging (MRI) (abbreviated, ultrafast, and contrast-agent free), may provide new opportunities for risk-adapted personalized screening strategies. Moreover, the integration of artificial intelligence and radiomics techniques has the potential to enhance the performance of risk-adapted screening. This review article summarizes the current evidence and challenges in breast cancer screening and highlights potential future perspectives for various imaging techniques in a risk-adapted breast cancer screening approach. EVIDENCE LEVEL: 1. TECHNICAL EFFICACY: Stage 5.
Topics: Female; Humans; Breast Neoplasms; Artificial Intelligence; Early Detection of Cancer; Mammography; Breast; Magnetic Resonance Imaging; Mass Screening
PubMed: 37040474
DOI: 10.1002/jmri.28731 -
Revue Medicale Suisse Apr 2024
Topics: Humans; Lung Neoplasms; Early Detection of Cancer; Tomography, X-Ray Computed; Mass Screening; Adult; Practice Guidelines as Topic
PubMed: 38665110
DOI: 10.53738/REVMED.2024.20.871.859 -
Revue Medicale Suisse Jun 2024
Topics: Humans; Colorectal Neoplasms; Early Detection of Cancer; Mass Screening; Occult Blood
PubMed: 38836399
DOI: 10.53738/REVMED.2024.20.877.1138 -
Revue Medicale Suisse May 2024
Topics: Humans; Colorectal Neoplasms; Early Detection of Cancer; Mass Screening; Occult Blood; Colonoscopy
PubMed: 38783676
DOI: 10.53738/REVMED.2024.20.875.1050 -
Obstetrics and Gynecology Clinics of... Jun 2024Female sexual dysfunction is highly prevalent, affecting 30% to 50% of cisgender women globally. Low sexual desire, sexual arousal disorder, and orgasm disorder affect... (Review)
Review
Female sexual dysfunction is highly prevalent, affecting 30% to 50% of cisgender women globally. Low sexual desire, sexual arousal disorder, and orgasm disorder affect 10% to 20%, 6% to 20%, and 4% to 14% of women, respectively. Dyspareunia or pain with intercourse affects 8% to 22% of women. Universal screening is recommended; and a thorough medical history and physical examination are the foundations of evaluation and assessment. Laboratory tests and imaging are sometimes warranted, but referral to a sexual medicine expert is suggested if the practitioner is unfamiliar or uncomfortable with treatment.
Topics: Humans; Female; Sexual Health; Sexual Dysfunctions, Psychological; Sexual Dysfunction, Physiological; Mass Screening; Dyspareunia; Physical Examination; Women's Health; Sexual Behavior
PubMed: 38777480
DOI: 10.1016/j.ogc.2024.03.002 -
Thoracic Surgery Clinics Aug 2023Screening with low-dose computed tomography has been shown to decrease lung cancer mortality. However, the issues of low detection rates and false positive results... (Review)
Review
Screening with low-dose computed tomography has been shown to decrease lung cancer mortality. However, the issues of low detection rates and false positive results remain, highlighting the need for adjunctive tools in lung cancer screening. To this end, researchers have investigated easily applicable, minimally invasive tests with high validity. We herein review some of the more promising novel markers utilizing plasma, sputum, and airway samples.
Topics: Humans; Lung Neoplasms; Early Detection of Cancer; Lung; Sputum; Tomography, X-Ray Computed; Mass Screening
PubMed: 37414477
DOI: 10.1016/j.thorsurg.2023.04.011